tozorakimab   Click here for help

GtoPdb Ligand ID: 12964

Synonyms: MEDI-3506 | MEDI3506
Immunopharmacology Ligand
Compound class: Antibody
Comment: Tozorakimab (MEDI3506) is a high-affinity anti-IL-33 monoclonal antibody. It inhibits IL-33-induced signalling to produce a anti-inflammatory effects [3]. Tozorakimab blocks the actions of both reduced IL-33 (IL-33red) and oxidized IL-33 (IL-33ox) metabolites through their respective downstream pathways (ST2 for IL-33red, RAGE/EGFR complex for IL-33ox) [1,7,9]. Activation of the RAGE/EGFR signaling cascade affects mucus production, which is a known driver of both disease exacerbations, and epithelial pathogenesis in COPD patients [8].
Bioactivity Comments
Tozorakimab disrupts signalling via the ST2 and RAGE/EGFR pathways. This action suppresses lung inflammation and reduces mucus dysfunction.
Selectivity at ligand targets
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
IL-33 Hs Antibody Binding 10.1 pIC50 - 3
⤷ pIC50 10.1 (IC50 8.2x10-11 M) [3]
Description: Potency for binding between antibody and IL33red.